CG Oncology Earnings
NASDAQ: CGONHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD
63.82+0.56 (+0.89%)
At close: Oct 9, 4:00 PM ET · Delayed 15 min
After hours: 63.82 0.00%
CG Oncology earnings summary
In its most recent report on Aug 6, 2026 (Q2 2026), CGON posted EPS of $-0.90. Revenue for the quarter was $1.2 million. Across the last 10 reports, CGON shares moved an average of 6.0% (in either direction) in the first trading session after results, rising 7 times and falling 3 times.
Summary generated from market data by MetaCap's automated system. Methodology
CGON earnings history
| Report date | EPS est. | EPS actual | Surprise | Price reaction |
|---|---|---|---|---|
| Aug 6, 2026 | — | $-0.90 | — | -0.1% |
| May 8, 2026 | — | $-0.71 | — | -3.9% |
| Feb 27, 2026 | — | $-0.52 | — | +5.2% |
| Nov 14, 2025 | — | $-0.57 | — | +3.5% |
| Aug 8, 2025 | — | $-0.54 | — | +3.4% |
| May 13, 2025 | — | $-0.45 | — | +0.0% |
| Mar 28, 2025 | — | $-0.47 | — | -34.9% |
| Nov 12, 2024 | — | $-0.30 | — | +1.7% |
| Aug 8, 2024 | — | $-0.28 | — | +1.8% |
| May 9, 2024 | — | $-0.36 | — | +5.2% |
Surprise compares reported EPS with the consensus estimate. Price reaction is the close-to-close move in the first session after the report. Learn about the earnings surprise.